Kentaro Ochi

Chikushino-shi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study.

Metabolic and endocrinological effects of weekly growth hormone replacement therapy with somapacitan in patients with adult growth hormone deficiency after switching from daily growth hormone replacement therapy: A real-world exploratory cohort study.

Journal: Drug discoveries & therapeutics
Published: June 14, 2026

Case Report: Adrenocortical adenoma harboring atypical subclinical Cushing's syndrome with dehydroepiandrosterone sulfate transferase and cytochrome b5 expression in tumor cells.

Case Report: Adrenocortical adenoma harboring atypical subclinical Cushing's syndrome with dehydroepiandrosterone sulfate transferase and cytochrome b5 expression in tumor cells.

Journal: Frontiers in endocrinology
Published: May 07, 2025

Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study.

Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study.

Journal: Medicine
Published: September 25, 2023

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas.

Clinical evaluations of pituitary apoplexy in incidental nonfunctional pituitary adenomas.

Journal: Medicine
Published: December 23, 2022

Clinical investigation of a unique type of hypothalamic adrenal insufficiency.

Clinical investigation of a unique type of hypothalamic adrenal insufficiency.

Journal: Medicine
Published: October 18, 2022

A simplified prediction model for end-stage kidney disease in patients with diabetes.

A simplified prediction model for end-stage kidney disease in patients with diabetes.

Journal: Scientific reports
Published: March 11, 2022

Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel NR0B1 Mutation.

Inhibition of NR5A1 Phosphorylation Alleviates a Transcriptional Suppression Defect Caused by a Novel NR0B1 Mutation.

Journal: Journal of the Endocrine Society
Published: January 10, 2022

Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report.

Adrenal Hemorrhage in a Cortisol-Secreting Adenoma Caused by Antiphospholipid Syndrome Revealed by Clinical and Pathological Investigations: A Case Report.

Journal: Frontiers in endocrinology
Published: September 02, 2021

Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism.

Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism.

Journal: Journal of bone and mineral metabolism
Published: October 06, 2020

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.

Investigation of efficacy and safety of low-dose sodium glucose transporter 2 inhibitors and differences between two agents, canagliflozin and ipragliflozin, in patients with type 2 diabetes mellitus.

Journal: Drug discoveries & therapeutics
Published: January 21, 2020

Clinical investigation of pituitary incidentalomas: A two-center study.

Clinical investigation of pituitary incidentalomas: A two-center study.

Journal: Intractable & rare diseases research
Published: January 01, 2020

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters.

Effect of denosumab, a human monoclonal antibody of receptor activator of nuclear factor kappa-B ligand (RANKL), upon glycemic and metabolic parameters: Effect of denosumab on glycemic parameters.

Journal: Medicine
Published: November 26, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026